#FacesOfMyeloma: Maureen’s path to living well with myeloma
My name is Maureen , and I was diagnosed with Myeloma in 2017 at the age of 55 and was fortunate to have been invited to join a clinical trial. This was successful and my myeloma…
My name is Maureen , and I was diagnosed with Myeloma in 2017 at the age of 55 and was fortunate to have been invited to join a clinical trial. This was successful and my myeloma…
My name is Ritva, and I live in Finland. I got my myeloma diagnosis four and a half years ago, when I was 63 years old. The first days after the diagnosis, I thought this…
My name is Ariunsanaa and last year my mother was diagnosed with myeloma. At that time, both my sibling and I were living abroad. We soon realised there was no available treatment in our hometown,…
My name is Wouter, I am living in The Netherlands, and I am 55 years old. In March 2024, I was diagnosed with myeloma, which turned my world upside down. One of the biggest challenges…
The European Young Myeloma Patients Group, created by Myeloma Patients Europe (MPE), invites you to a webinar focused on myeloma and physical fitness on Wednesday, 26 February 2025, from 16:00 – 17:00 CET. This session…
On 22 January 2025, the European Commission approved an isatuximab combination for the treatment of newly diagnosed myeloma patients who are not eligible for a stem cell transplant in the EU. This follows a positive recommendation…
At the 2024 American Society of Hematology (ASH) Annual Meeting, Myeloma Patients Europe (MPE) interviewed experts about the most interesting studies and abstracts in myeloma and AL amyloidosis research that were presented during the conference.…
The American Society of Hematology (ASH) Annual Meeting, the world’s largest haematology conference, will take place from 7 – 10 December in San Diego, United States. It is a very exciting event for the myeloma…